Hepatoblastoma staging: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 5: Line 5:
The staging of hepatoblastoma is based on the Intergroup staging system.
The staging of hepatoblastoma is based on the Intergroup staging system.
==Staging==
==Staging==
The staging of hepatoblastoma is based on the Intergroup staging system:<ref name=staging>Intergroup staging system of hepatoblastoma. Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/hepatoblastoma-staging-2. Accessed on November 3, 2015</ref>
The staging of hepatoblastoma is based on the Intergroup staging system:<ref name="staging">Intergroup staging system of hepatoblastoma. Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/hepatoblastoma-staging-2. Accessed on November 3, 2015</ref>


{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px"
{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px"
|valign=top|
| valign="top" |
|+
|+
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF|'''Stage'''}}
! style="background: #4479BA; width: 100px;" | {{fontcolor|#FFF|'''Stage'''}}
Line 15: Line 15:
|-
|-
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage I'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage I'''}}
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Complete surgical resection
*Complete surgical resection
|-
|-
Line 21: Line 21:


|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IIa'''
'''Stage IIa'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Complete macroscopic surgical resection
*Complete macroscopic surgical resection
*Intrahepatic residual microscopic disease
*Intrahepatic residual microscopic disease
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IIb'''
'''Stage IIb'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Complete macroscopic surgical resection
*Complete macroscopic surgical resection
*Extrahepatic residual microscopic disease
*Extrahepatic residual microscopic disease
Line 35: Line 35:
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage III'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage III'''}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IIIa'''
'''Stage IIIa'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Incomplete surgical resection with macroscopic residual
*Incomplete surgical resection with macroscopic residual
*Significant tumour spill
*Significant tumour spill
Line 43: Line 43:
*Positive lymph node disease
*Positive lymph node disease
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IIIb'''
'''Stage IIIb'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Tumor not resected
*Tumor not resected
|-
|-
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage IV'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Stage IV'''}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IVa'''
'''Stage IVa'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Distant metastatic disease
*Distant metastatic disease
*Primary tumor completely resected
*Primary tumor completely resected
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align="center" |
'''Stage IVb'''
'''Stage IVb'''
| style="padding: 5px 5px; background: #F5F5F5;" align=left|
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
*Distant metastatic disease
*Distant metastatic disease
*Primary tumor incompletely resected
*Primary tumor incompletely resected
Line 64: Line 64:


==References==
==References==
{{reflist|2}}
{{reflist|1}}


[[Category:Disease]]
[[Category:Disease]]
Line 74: Line 74:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Surgery]]
[[Category:Hepatology]]

Latest revision as of 20:37, 13 March 2019

Hepatoblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Hepatoblastoma from other Diseases

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatoblastoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatoblastoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatoblastoma staging

CDC on Hepatoblastoma staging

Hepatoblastoma staging in the news

Blogs on Hepatoblastoma staging

Directions to Hospitals Treating Hepatoblastoma

Risk calculators and risk factors for Hepatoblastoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

The staging of hepatoblastoma is based on the Intergroup staging system.

Staging

The staging of hepatoblastoma is based on the Intergroup staging system:[1]

Stage Description
Stage I
  • Complete surgical resection
Stage II

Stage IIa

  • Complete macroscopic surgical resection
  • Intrahepatic residual microscopic disease

Stage IIb

  • Complete macroscopic surgical resection
  • Extrahepatic residual microscopic disease
Stage III

Stage IIIa

  • Incomplete surgical resection with macroscopic residual
  • Significant tumour spill
  • Positive lymph node disease

Stage IIIb

  • Tumor not resected
Stage IV

Stage IVa

  • Distant metastatic disease
  • Primary tumor completely resected

Stage IVb

  • Distant metastatic disease
  • Primary tumor incompletely resected

References

  1. ↑ Intergroup staging system of hepatoblastoma. Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/hepatoblastoma-staging-2. Accessed on November 3, 2015


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Hepatoblastoma_staging&oldid=1557990"